Pharma

Your Article Summary

See Latest Articles

Bernhard Hampl, Ph.D. Elected to Serve as Executive Chairman of the Board of Directors of Fresenius Kabi Pharmaceuticals Holding, Inc
American Pharmaceutical Partners, 11/03/09

Fresenius Kabi Pharmaceuticals Holding, Inc., which acquired APP Pharmaceuticals, Inc., September 2008, announced the election of Bernhard Hampl, Ph.D. to its Board of Directors effective November 2009. Dr. Hampl, also named as Executive Chairman of the Board, succeeds current Chairman Dr. Ulf M. Schneider. Dr. Schneider will continue to serve on the Board of Directors and as a member of the Audit Committee.

Today in Execs on the Move...keeping you current

Receive free subspecialty "5-minute updates" via email

New CEO announced for CAMH
Canadian Healthcare Technology, 11/20/09

Mylans President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
Mylan, 11/19/09

Storrer to Lead MEDecision
HealthDataManagement, 11/18/09

 See all of Execs on the Move